1 results
29/Mar/2022
29/Mar/2022
DOI: 10.31744/einstein_journal/2022AO6453
ABSTRACT Objective To evaluate the therapeutic response (functionality) and its associated factors in patients on biological drugs on the Public Health System for treatment of rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Methods An open prospective cohort was carried out from 2011 to 2019, in Belo Horizonte (MG). Functionality was assessed using the Health Assessment Questionnaire Disability-Index at baseline, and after 6 and 12 months of follow-up. Factors associated with poor functionality were identified through logistic regression. Results The median […]
Keywords: Arthritis, psoriatic; Arthritis, rheumatoid; Biological products; Effectiveness; Rheumatic diseases; Spondylitis, ankylosing; Unified Health System